Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Povorcitinib phosphate by Incyte for Prurigo: Likelihood of Approval
Povorcitinib phosphate is under clinical development by Incyte and currently in Phase II for Prurigo. According to GlobalData, Phase II...
Povorcitinib phosphate by Incyte for Chronic Urticaria Or Hives: Likelihood of Approval
Povorcitinib phosphate is under clinical development by Incyte and currently in Phase II for Chronic Urticaria Or Hives. According to...
Povorcitinib phosphate by Incyte for Asthma: Likelihood of Approval
Povorcitinib phosphate is under clinical development by Incyte and currently in Phase II for Asthma. According to GlobalData, Phase II...
Povorcitinib phosphate by Incyte for Vitiligo: Likelihood of Approval
Povorcitinib phosphate is under clinical development by Incyte and currently in Phase III for Vitiligo. According to GlobalData, Phase III...